Another pilot study using the non‐primate ischemic stroke models has proven that NEUROD1 is able to convert reactive astrocytes to neurons from 10 to 30 days following the onset, suggesting that in vivo AtN conversion may have a broad therapeutic time window [18]. The gene discussed is NEUROD1; the disease is ischemic stroke.